Profile picture

Mr Maximilian Mueller

German Heart Centre Berlin, Berlin (Germany)
Follow
Logo ESC

Contributor content

Bioactive adrenomedullin as a predictor of clinical outcomes in cardiac transthyretin amyloidosis
Presentation
Bioactive adrenomedullin as a predictor of clinical outcomes in cardiac transthyretin amyloidosis
Prognostic staging system correctly identifies high risk groups in cardiac transthyretin amyloidosis treated with tafamidis
Presentation
Prognostic staging system correctly identifies high risk groups in cardiac transthyretin amyloidosis treated with tafamidis

ESC 365 is supported by